about
MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathwayArrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcriptionLMNA knock-down affects differentiation and progression of human neuroblastoma cellsMYC prevents apoptosis and enhances endoreduplication induced by paclitaxel.Human placenta-derived neurospheres are susceptible to transformation after extensive in vitro expansion.Signaling by exosomal microRNAs in cancer.Flow cytometric analysis of ploidy in colorectal cancer: a multicentric experience.Down-regulation of the Lamin A/C in neuroblastoma triggers the expansion of tumor initiating cells.MYCN gene expression is required for the onset of the differentiation programme in neuroblastoma cells.Differentiation of Caco-2 cells requires both transcriptional and post-translational down-regulation of Myc.CPTH6, a thiazole derivative, induces histone hypoacetylation and apoptosis in human leukemia cells.Ago1 and Ago2 differentially affect cell proliferation, motility and apoptosis when overexpressed in SH-SY5Y neuroblastoma cells.Temozolomide induced c-Myc-mediated apoptosis via Akt signalling in MGMT expressing glioblastoma cells.Cell growing density affects the structural and functional properties of Caco-2 differentiated monolayer.UDP exerts cytostatic and cytotoxic actions in human neuroblastoma SH-SY5Y cells over-expressing P2Y6 receptor.Oligopeptides impairing the Myc-Max heterodimerization inhibit lung cancer cell proliferation by reducing Myc transcriptional activity.c-MYC deregulation is involved in melphalan resistance of multiple myeloma: role of PDGF-BB.Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.In vitro and in vivo tumor growth inhibition by a p16-mimicking peptide in p16INK4A-defective, pRb-positive human melanoma cells.Adriamycin resistance modulation induced by lonidamine in human breast cancer cells.N-methylformamide as a potential therapeutic approach in colon cancer.Neural stem cells modified to express BDNF antagonize trimethyltin-induced neurotoxicity through PI3K/Akt and MAP kinase pathways.Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy.Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt.RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines.Effects of poly(ADP-ribose) polymerase inhibition on cell death and chromosome damage induced by VP16 and bleomycin.Gemcitabine treatment of experimental C6 glioma: the effects on cell cycle and apoptotic rate.Lamin A/C Is Required for ChAT-Dependent Neuroblastoma Differentiation.Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.Flow cytometric analysis of DNA content and cell kinetics in colorectal carcinoma.Study of propidium iodide binding to DNA in intact cells by flow cytometry.DNA Ploidy, Cell Kinetics, and Epidermal Growth Factor Receptor and HER2/neu Oncoprotein Expression in Primary Operable Breast CancerRecombinant tumor necrosis factor for superficial bladder tumorsImportance of cell cycle perturbations on the effectiveness of N-methylformamide and anti-neoplastic drugs in combinationExpression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypesnm23 influences proliferation and differentiation of PC12 cells in response to nerve growth factorDNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancersMethylation state of the human HLA-DRA gene in T-lymphocytes and B-lymphocytes of transgenic mice. Lack of methylation at one 5'-GCGC site is not required for gene expressionGastric cancer cell DNA content correlates with early and late results after gastrectomy
P50
Q24337839-A239DCB9-DD37-4B30-9ACC-36ED8AE41050Q24554293-0198AB10-1FF2-4A99-B05B-4C35E6A1E6B1Q28484053-9F762421-EC7B-443D-8E21-87D14F491B65Q33440553-B1990008-E077-4DF7-A6EF-0A1267EA11C3Q33746589-BD7A6C4D-D782-4A31-9F21-AC734495844BQ35344075-0D1AA7B8-0B59-468F-9BA3-837E85FA513BQ35976841-7C087B6D-466F-411F-8810-33B628185209Q36544990-D166C7CD-41CD-4E91-8EF5-6C632DA432E7Q39022048-21EA26E6-255F-4267-8EB3-E99AE842D8AFQ39390441-5A7DF0A2-71D9-4A2B-8CF3-D594F0BB2510Q39446176-7740EF83-2F1C-4565-861A-224FAE2539DCQ39489520-D52AB08A-8582-40CC-8B7C-020C4608F0ECQ39575976-18F6D01B-C5FE-42A4-920E-825B0E7BD4DCQ39644382-8F2535B4-69EE-4FCF-A65D-5839B4543363Q39741722-4B7DDF17-23D2-4F44-84CA-87709D359640Q40228065-C51774D4-E938-401A-88FB-ADE4A25C11B6Q40299012-73D6C56F-9DA1-42D4-8831-FF5125E61C69Q40438002-1FF9487A-8183-4DF0-B401-536E3586B8C6Q40511673-4D5085E4-8B52-4C47-90B9-7DC8CADFA9CFQ41274179-38AB12E8-B563-4E8C-84CE-8968127C84A6Q41488673-E89F1638-983A-48A5-9726-664134D5E231Q43078670-EA81692A-F9D7-4997-BF71-08CE14CEDFF5Q43442231-FED59C13-3049-4C8B-A1BD-DF6846B28CFDQ43735445-8A567202-3F93-4E05-B382-ABDC0DDF57A6Q44945718-D7BE1AD7-004A-4757-816A-A7A4B71D5F14Q45664343-D5FDE6A5-C4C8-401C-99DE-587B63909EBCQ47676072-4236B2C0-4D5E-43BC-8E16-7569930B3EE0Q48455950-08A5A013-31A4-4EE8-83F3-753355889069Q48715178-42035862-F886-4439-97F0-E5AF786B041AQ50750187-D1272CA1-8D2D-42F2-A610-455B77F00F2FQ52397031-21656F1C-980E-4F62-9F98-D627FBC7F8C8Q52467812-A28798D7-8A72-4F10-B3F6-C9EC4B361A48Q61232469-226D07DD-E1DB-4BEE-98D3-2F81FB601DA5Q67592415-E446ABA1-BC2F-4AFB-961F-5BF2B7F51F7BQ70167667-50CA9ED5-6DC4-4688-B80E-E026FAA3E055Q71604126-FA72B0E8-9C6D-4824-A944-C17747CDD22BQ71872000-701AA926-FC57-49AD-B6A6-C663F6F0F01CQ72171948-B9262CC4-124D-4C55-8402-C0D75A9A75C3Q72679055-949FAFE5-78A3-4355-8E4B-4752C0316FE6Q72721796-2DCA7E39-132D-4BB9-B4E9-596F2490CE24
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Igea D'Agnano
@ast
Igea D'Agnano
@en
Igea D'Agnano
@es
Igea D'Agnano
@nl
Igea D'Agnano
@sl
type
label
Igea D'Agnano
@ast
Igea D'Agnano
@en
Igea D'Agnano
@es
Igea D'Agnano
@nl
Igea D'Agnano
@sl
prefLabel
Igea D'Agnano
@ast
Igea D'Agnano
@en
Igea D'Agnano
@es
Igea D'Agnano
@nl
Igea D'Agnano
@sl
P106
P31
P496
0000-0002-2646-9224